Joel Sendek Insider Trading $SPRO Spero Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Joel Sendek.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Joel Sendek. Joel Sendek is Chief Financial Officer in Spero Therapeutics, Inc. ($SPRO).
Joel Sendek in Spero Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Joel Sendek: Chief Financial Officer
Holdings: 17,181 shares
Latest Transaction: Jan 02 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Joel Sendek in Spero Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 02 2019 | SPRO | Spero Therapeutics ... | Sendek Joel | Chief Financial Off ... | Option Exercise | A | 6.26 | 65,000 | 406,900 | 65,000 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Sendek Joel | Chief Financial Off ... | Option Exercise | M | 5.90 | 2,000 | 11,800 | 165,833 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Sendek Joel | Chief Financial Off ... | Sell | S | 17.50 | 2,000 | 35,000 | 15,181 | 17.2 K to 15.2 K (-11.64 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Sendek Joel | Chief Financial Off ... | Buy | M | 5.90 | 2,000 | 11,800 | 17,181 | 15.2 K to 17.2 K (+13.17 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Sendek Joel | Chief Financial Off ... | Option Exercise | M | 5.90 | 2,000 | 11,800 | 165,833 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Sendek Joel | Chief Financial Off ... | Sell | S | 17.50 | 2,000 | 35,000 | 15,181 | 17.2 K to 15.2 K (-11.64 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Sendek Joel | Chief Financial Off ... | Buy | M | 5.90 | 2,000 | 11,800 | 17,181 | 15.2 K to 17.2 K (+13.17 %) |
| Dec 15 2017 | SPRO | Spero Therapeutics ... | Sendek Joel | Chief Financial Off ... | Option Exercise | A | 11.63 | 27,795 | 323,256 | 27,795 | |
| Nov 07 2017 | SPRO | Spero Therapeutics ... | Sendek Joel | Chief Financial Off ... | Option Exercise | C | 0.00 | 61,880 | 0 | 0 | |
| Nov 07 2017 | SPRO | Spero Therapeutics ... | Sendek Joel | Chief Financial Off ... | Buy | P | 14.00 | 5,000 | 70,000 | 15,181 | 10.2 K to 15.2 K (+49.11 %) |
| Nov 07 2017 | SPRO | Spero Therapeutics ... | Sendek Joel | Chief Financial Off ... | Buy | C | 0.00 | 10,181 | 0 | 10,181 | 0 to 10.2 K |
Page: 1